Your browser doesn't support javascript.
loading
An ELISA-based assay for determining haemagglutinin potency in egg, cell, or recombinant protein derived influenza vaccines.
Bodle, Jesse; Vandenberg, Kirsten; Laurie, Karen; Barr, Ian G; Zhang, Ying; Rockman, Steven.
Affiliation
  • Bodle J; Vaccine Product Development, CSL Seqirus Ltd, Parkville, VIC, Australia.
  • Vandenberg K; Vaccine Product Development, CSL Seqirus Ltd, Parkville, VIC, Australia.
  • Laurie K; Vaccine Product Development, CSL Seqirus Ltd, Parkville, VIC, Australia.
  • Barr IG; Collaborating Centre for Reference and Research on Influenza, World Health Organisation, Melbourne, VIC, Australia.
  • Zhang Y; Vaccine Product Development, CSL Seqirus Ltd, Holly Springs, NC, United States.
  • Rockman S; Vaccine Product Development, CSL Seqirus Ltd, Parkville, VIC, Australia.
Front Immunol ; 14: 1147028, 2023.
Article in En | MEDLINE | ID: mdl-37033922

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Recombinant Proteins / Enzyme-Linked Immunosorbent Assay / Influenza Vaccines / Cells / Eggs / Hemagglutinins Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Front Immunol Year: 2023 Type: Article Affiliation country: Australia

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Recombinant Proteins / Enzyme-Linked Immunosorbent Assay / Influenza Vaccines / Cells / Eggs / Hemagglutinins Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Front Immunol Year: 2023 Type: Article Affiliation country: Australia